Save your place

Sign in to WhoBought

Please try again later.

IN8bio, Inc. (INAB) institutional ownership

Market cap$9.2M SectorHealthcare
Funds holding · Q1 2026
17
reported INAB position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
6 buyers · 11 sellers

IN8bio, Inc. (INAB) price and institutional activity

Dates

Q1 2026

$0 bought by 6 investors
Stonepine Capital Management, LLCVanguard +4 more
$0 sold by 11 investors
Bios Capital Management, LPTwo Sigma Advisers, LP +9 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

IN8bio, Inc. (INAB) institutional activity · 17

Investor Type Est. change Change Δ Own Date
Stonepine Capital Management, LLC · Added
Change +499K Date Q1 2026
Stonepine Capital Management, LLC Added· Q1 2026 +499K Q1 2026
Vanguard · Added
Change +104K Date Q1 2026
Vanguard Added· Q1 2026 +104K Q1 2026
Bios Capital Management, LP · Reduced
Change −86K Date Q1 2026
Bios Capital Management, LP Reduced· Q1 2026 −86K Q1 2026
Geode · Added
Change +65K Date Q1 2026
Geode Added· Q1 2026 +65K Q1 2026
Two Sigma Advisers, LP · Exited
Change −36K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −36K −100.0% Q1 2026
Two Sigma Investments, LP · Exited
Change −28K Δ Own −100.0% Date Q1 2026
Two Sigma Investments, LP Exited· Q1 2026 −28K −100.0% Q1 2026
Oppenheimer & Co Inc · New
Change +24K Date Q1 2026
Oppenheimer & Co Inc New· Q1 2026 +24K Q1 2026
Captrust Financial Advisors · Added
Change +15K Date Q1 2026
Captrust Financial Advisors Added· Q1 2026 +15K Q1 2026
Hrt Financial LP · Exited
Change −15K Δ Own −100.0% Date Q1 2026
Hrt Financial LP Exited· Q1 2026 −15K −100.0% Q1 2026
Alyeska Investment Group, L.P. · Reduced
Change −13K Date Q1 2026
Alyeska Investment Group, L.P. Reduced· Q1 2026 −13K Q1 2026
Xtx Topco Ltd · Reduced
Change −5K Date Q1 2026
Xtx Topco Ltd Reduced· Q1 2026 −5K Q1 2026
Northern Trust · Added
Change +3K Date Q1 2026
Northern Trust Added· Q1 2026 +3K Q1 2026
Tower Research Capital LLC (trc) · Reduced
Change −1K Date Q1 2026
Tower Research Capital LLC (trc) Reduced· Q1 2026 −1K Q1 2026
Jones Financial Companies Lllp · Reduced
Change −460 Date Q1 2026
Jones Financial Companies Lllp Reduced· Q1 2026 −460 Q1 2026
UBS Group AG · Reduced
Change −297 Date Q1 2026
UBS Group AG Reduced· Q1 2026 −297 Q1 2026
Data through Q1 2026 · filed May 27, 2026
15 of 17

Famous investor activity in IN8bio, Inc. (INAB)

IN8bio, Inc. (INAB) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Fairbairn Emily · Director Gift (G) -725K
Owned 0 Trade date May 27, 2026 Filed date May 29, 2026
Fairbairn Emily Director Gift (G) -725K 0 May 27, 2026 May 29, 2026
Ho William Tai-Wei · Director Grant (A) 154K
Owned 154K Trade date May 9, 2026 Filed date May 12, 2026
Ho William Tai-Wei Director Grant (A) 154K 154K May 9, 2026 May 12, 2026
Greenwood Luba · Director Grant (A) 22K
Owned 22K Trade date May 9, 2026 Filed date May 12, 2026
Greenwood Luba Director Grant (A) 22K 22K May 9, 2026 May 12, 2026
Lamb Lawrence · Officer Grant (A) 54K
Owned 54K Trade date May 9, 2026 Filed date May 12, 2026
Lamb Lawrence Officer Grant (A) 54K 54K May 9, 2026 May 12, 2026
Fairbairn Emily · Director Grant (A) 22K
Owned 22K Trade date May 9, 2026 Filed date May 12, 2026
Fairbairn Emily Director Grant (A) 22K 22K May 9, 2026 May 12, 2026
McCall Patrick · CFO Grant (A) 56K
Owned 56K Trade date May 9, 2026 Filed date May 12, 2026
McCall Patrick CFO Grant (A) 56K 56K May 9, 2026 May 12, 2026
Rochlin Kate · Officer Grant (A) 60K
Owned 60K Trade date May 9, 2026 Filed date May 12, 2026
Rochlin Kate Officer Grant (A) 60K 60K May 9, 2026 May 12, 2026
Epperly Corinne · Director Grant (A) 22K
Owned 22K Trade date May 9, 2026 Filed date May 12, 2026
Epperly Corinne Director Grant (A) 22K 22K May 9, 2026 May 12, 2026
Brandt Peter C. · Director Grant (A) 22K
Owned 22K Trade date May 9, 2026 Filed date May 12, 2026
Brandt Peter C. Director Grant (A) 22K 22K May 9, 2026 May 12, 2026
Graff Jeremy R. · Director Grant (A) 22K
Owned 22K Trade date May 9, 2026 Filed date May 12, 2026
Graff Jeremy R. Director Grant (A) 22K 22K May 9, 2026 May 12, 2026
Lamb Lawrence · Officer Grant (A) 72K
Owned 72K Trade date Feb 4, 2026 Filed date Feb 6, 2026
Lamb Lawrence Officer Grant (A) 72K 72K Feb 4, 2026 Feb 6, 2026
McCall Patrick · Officer Grant (A) 75K
Owned 75K Trade date Feb 4, 2026 Filed date Feb 6, 2026
McCall Patrick Officer Grant (A) 75K 75K Feb 4, 2026 Feb 6, 2026
Rochlin Kate · Officer Grant (A) 80K
Owned 80K Trade date Feb 4, 2026 Filed date Feb 6, 2026
Rochlin Kate Officer Grant (A) 80K 80K Feb 4, 2026 Feb 6, 2026
Ho William Tai-Wei · Director, Officer, 10% Owner Grant (A) 206K
Owned 206K Trade date Feb 4, 2026 Filed date Feb 6, 2026
Ho William Tai-Wei Director, Officer, 10% Owner Grant (A) 206K 206K Feb 4, 2026 Feb 6, 2026
Rochlin Kate · Officer Grant (A) $10K
Price $1.38 Qty 7K Owned 9K Trade date Dec 22, 2025 Filed date Dec 23, 2025
Rochlin Kate Officer Grant (A) $1.38 7K $10K 9K Dec 22, 2025 Dec 23, 2025
15 of 20
15 of 20 Sign in to continue to older insider transactions.

IN8bio, Inc. (INAB) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Lytton Laurence W 984K
% of shares outstanding 10.0% Filing date Mar 2, 2026
Lytton Laurence W 984K 10.0% Mar 2, 2026
Alyeska Investment Group, L.P. 966K
% of shares outstanding 9.9% Filing date Feb 17, 2026
Alyeska Investment Group, L.P. 966K 9.9% Feb 17, 2026
Stonepine Capital Management, LLC 1.0M
% of shares outstanding 9.9% Filing date Dec 22, 2025
Stonepine Capital Management, LLC 1.0M 9.9% Dec 22, 2025
683 Capital Management, LLC 770K
% of shares outstanding 7.9% Filing date Dec 30, 2025
683 Capital Management, LLC 770K 7.9% Dec 30, 2025
Orin Hirschman 150K
% of shares outstanding 4.4% Filing date Jul 29, 2025
Orin Hirschman 150K 4.4% Jul 29, 2025
William Tai-Wei Ho 151K
% of shares outstanding 3.7% Filing date Aug 13, 2025
William Tai-Wei Ho 151K 3.7% Aug 13, 2025
Transcend Partners Opportunity Fund LLC 107K
% of shares outstanding 2.6% Filing date Aug 13, 2025
Transcend Partners Opportunity Fund LLC 107K 2.6% Aug 13, 2025
Bios Fund Ii, LP 574K
% of shares outstanding 1.3% Filing date Dec 15, 2023
Bios Fund Ii, LP 574K 1.3% Dec 15, 2023
8 of 8

IN8bio, Inc. (INAB) ownership FAQ

Who owns INAB?

17 reporting institutions disclosed INAB position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.